Yang, H.; Gan, L.; Zhang, H.
Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs. Pharmaceuticals 2025, 18, 696.
https://doi.org/10.3390/ph18050696
AMA Style
Yang H, Gan L, Zhang H.
Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs. Pharmaceuticals. 2025; 18(5):696.
https://doi.org/10.3390/ph18050696
Chicago/Turabian Style
Yang, Hailong, Lu Gan, and Huabei Zhang.
2025. "Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs" Pharmaceuticals 18, no. 5: 696.
https://doi.org/10.3390/ph18050696
APA Style
Yang, H., Gan, L., & Zhang, H.
(2025). Design, Synthesis, Anticancer Evaluation and Molecular Docking of Pyrimidine, Pyrido[4,3-d]pyrimidine and 5,6,7,8-Tetrahydropyrido[3,4-d]pyrimidine Derivatives as Novel KRAS-G12D Inhibitors and PROTACs. Pharmaceuticals, 18(5), 696.
https://doi.org/10.3390/ph18050696